133 related articles for article (PubMed ID: 16459149)
41. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
[TBL] [Abstract][Full Text] [Related]
42. RETRACTED: Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis.
Guo SS; Liu R; Wen YF; Liu LT; Yuan L; Li YX; Li Y; Hao WW; Peng JY; Chen DN; Tang QN; Sun XS; Guo L; Mo HY; Qian CN; Zeng MS; Bei JX; Sun SY; Chen QY; Tang LQ; Mai HQ
Cancer Lett; 2020 Jan; 468():27-40. PubMed ID: 31604115
[TBL] [Abstract][Full Text] [Related]
43. RETRACTED: Protective autophagy induced by physcion suppresses hepatocellular carcinoma cell metastasis by inactivating the JAK2/STAT3 Axis.
Pan X; Wang C; Li Y; Zhu L; Zhang T
Life Sci; 2018 Dec; 214():124-135. PubMed ID: 30389439
[TBL] [Abstract][Full Text] [Related]
44. Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice.
Su C; Peng L; Sham J; Wang X; Zhang Q; Chua D; Liu C; Cui Z; Xue H; Wu H; Yang Q; Zhang B; Liu X; Wu M; Qian Q
Mol Ther; 2006 May; 13(5):918-27. PubMed ID: 16497559
[TBL] [Abstract][Full Text] [Related]
45. RETRACTED: LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis.
Dacheng W; Songhe L; Weidong J; Shutao Z; Jingjing L; Jiaming Z
Biomed Pharmacother; 2020 May; 125():110039. PubMed ID: 32187965
[TBL] [Abstract][Full Text] [Related]
46. Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma.
Su CQ; Wang XH; Chen J; Liu YJ; Wang WG; Li LF; Wu MC; Qian QJ
World J Gastroenterol; 2006 Dec; 12(47):7613-20. PubMed ID: 17171789
[TBL] [Abstract][Full Text] [Related]
47. RETRACTED: Long non-coding RNA HULC interacts with miR-613 to regulate colon cancer growth and metastasis through targeting RTKN.
Dong Y; Wei MH; Lu JG; Bi CY
Biomed Pharmacother; 2019 Jan; 109():2035-2042. PubMed ID: 30551459
[TBL] [Abstract][Full Text] [Related]
48. RETRACTED: KDM5B-mediated microRNA-448 up-regulation restrains papillary thyroid cancer cell progression and slows down tumor growth via TGIF1 repression.
Pu Y; Xiang J; Zhang J
Life Sci; 2020 Jun; 250():117519. PubMed ID: 32147429
[TBL] [Abstract][Full Text] [Related]
49. Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer.
Trujillo MA; Oneal MJ; Davydova J; Bergert E; Yamamoto M; Morris JC
Breast Cancer Res; 2009; 11(4):R53. PubMed ID: 19635153
[TBL] [Abstract][Full Text] [Related]
50. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy.
Zhang ZL; Zou WG; Luo CX; Li BH; Wang JH; Sun LY; Qian QJ; Liu XY
Cell Res; 2003 Dec; 13(6):481-9. PubMed ID: 14728805
[TBL] [Abstract][Full Text] [Related]
51. RETRACTED: Long noncoding RNA LCTS5 inhibits non-small cell lung cancer by interacting with INO80.
Wang B; Wang Y; Ma D; Wang L; Yang M
Life Sci; 2020 Jul; 253():117680. PubMed ID: 32305524
[TBL] [Abstract][Full Text] [Related]
52. RETRACTED: Effects of lentivirus-mediated silencing of Periostin on tumor microenvironment and bone metastasis via the integrin-signaling pathway in lung cancer.
Che J; Shen WZ; Deng Y; Dai YH; Liao YD; Yuan XL; Zhang P
Life Sci; 2017 Aug; 182():10-21. PubMed ID: 28601389
[TBL] [Abstract][Full Text] [Related]
53. RETRACTED: Physcion 8-O-β-glucopyranoside induced ferroptosis via regulating miR-103a-3p/GLS2 axis in gastric cancer.
Niu Y; Zhang J; Tong Y; Li J; Liu B
Life Sci; 2019 Nov; 237():116893. PubMed ID: 31606381
[TBL] [Abstract][Full Text] [Related]
54. Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer.
Stoff-Khalili MA; Rivera AA; Stoff A; Michael Mathis J; Rocconi RP; Matthews QL; Numnum MT; Herrmann I; Dall P; Eckhoff DE; Douglas JT; Siegal GP; Zhu ZB; Curiel DT
Int J Cancer; 2007 Feb; 120(4):935-41. PubMed ID: 17131341
[TBL] [Abstract][Full Text] [Related]
55. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
56. Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway.
Cascallo M; Alonso MM; Rojas JJ; Perez-Gimenez A; Fueyo J; Alemany R
Mol Ther; 2007 Sep; 15(9):1607-15. PubMed ID: 17579575
[TBL] [Abstract][Full Text] [Related]
57. [hTERT promoter regulated replication-selective adenovirus CNHK300 in treatment of hepatocellular carcinoma].
Li YM; Song ST; Jiang ZF; Zhang Q; Su CQ; Xu JM; Qian YZ; Qian QJ
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):468-72. PubMed ID: 15854553
[TBL] [Abstract][Full Text] [Related]
58. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
Hoffmann D; Meyer B; Wildner O
J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
[TBL] [Abstract][Full Text] [Related]
59. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
60. A novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent.
Zou W; Luo C; Zhang Z; Liu J; Gu J; Pei Z; Qian C; Liu X
Oncogene; 2004 Jan; 23(2):457-64. PubMed ID: 14724574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
